Camurus Revenue and Competitors
Estimated Revenue & Valuation
- Camurus's estimated annual revenue is currently $37.2M per year.
- Camurus's estimated revenue per employee is $201,000
Employee Data
- Camurus has 185 Employees.
- Camurus grew their employee count by 11% last year.
Camurus Competitors & Alternatives
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $14.9M | 74 | 9% | N/A | N/A |
#2 | $37.2M | 185 | 11% | N/A | N/A |
#3 | $18.5M | 92 | 19% | N/A | N/A |
#4 | $72.8M | 362 | 25% | N/A | N/A |
#5 | $1200M | 1066 | 90% | $2.4B | N/A |
#6 | $5.6M | 28 | 56% | N/A | N/A |
#7 | $6.6M | 33 | 106% | N/A | N/A |
#8 | $21.7M | 108 | 731% | N/A | N/A |
What Is Camurus?
Camurus is a Swedish research-based pharmaceutical company committed to developing and commercialising innovative and differentiated medicines for the treatment of severe and chronic conditions. New drug products with best-in-class potential are conceived based on the proprietary FluidCrystal® drug delivery technologies and an extensive R&D expertise. Camurus clinical pipeline includes products for treatment of cancer, endocrine diseases, pain and addiction, developed in-house and in collaboration with international pharmaceutical companies. The company's shares are listed on Nasdaq Stockholm under the ticker CAMX.
keywords:N/A
N/A
Total Funding
185
Number of Employees
$37.2M
Revenue (est)
11%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Camurus News
Nanotechnology in Drug Delivery Market Size, Share, Growth 2022-2029| Key Players Access Pharmaceuticals, Alkermes, Aquanova, Camurus.
... for the Forecast Period Between 2022 to 2028: BioDelivery Sciences, Camurus, Carlina Technologies, Cerulean Pharma, Nano Green Sciences.
Camurus : Proposal by the Board on authorization for the Board of Directors to resolve on issues · 1. The authorization may be exercised on one...
Other Companies in Lund
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $29.1M | 188 | 21% | N/A |
#2 | $35M | 196 | 22% | N/A |
#3 | $33M | 207 | N/A | N/A |
#4 | $47.2M | 296 | 3% | N/A |
#5 | $15M | 334 | 25% | N/A |
